Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seagen Inc.
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pathologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma Grade 3, diffuse large B-cell lymphoma (DLBCL), including transformed follicular histology, Burkitt lymphoma, or B-lineage lymphoblastic lymphoma
Relapsed, refractory, or progressive disease following at least 1 prior systemic therapy. Patients with DLBCL or follicular lymphoma Grade 3 must have also received intensive salvage therapy.
Eastern Cooperative Oncology Group status of 0 or 1
Measurable disease
You may not be if
Allogeneic stem cell transplant (SCT)
Clareo Health | A Safety Study of SGN-CD19A for B-Cell Lymphoma
